Your Good Partner in Biology Research

  1. 首頁(yè)
  2. 蛋白
  3. 重組蛋白
  4. Recombinant Human Cbp/p300-interacting transactivator 2 (CITED2)

Recombinant Human Cbp/p300-interacting transactivator 2 (CITED2)

  • 中文名稱(chēng)：
    Recombinant Human Cbp/p300-interacting transactivator 2(CITED2),Yeast
  • 貨號(hào)：
    CSB-YP859529HU
  • 規(guī)格：
  • 來(lái)源：
    Yeast
  • 其他：
  • 中文名稱(chēng)：
    Recombinant Human Cbp/p300-interacting transactivator 2(CITED2),Yeast
  • 貨號(hào)：
    CSB-EP859529HU
  • 規(guī)格：
  • 來(lái)源：
    E.coli
  • 其他：
  • 中文名稱(chēng)：
    Recombinant Human Cbp/p300-interacting transactivator 2(CITED2),Yeast
  • 貨號(hào)：
    CSB-EP859529HU-B
  • 規(guī)格：
  • 來(lái)源：
    E.coli
  • 共軛：
    Avi-tag Biotinylated

    E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.

  • 其他：
  • 中文名稱(chēng)：
    Recombinant Human Cbp/p300-interacting transactivator 2(CITED2),Yeast
  • 貨號(hào)：
    CSB-BP859529HU
  • 規(guī)格：
  • 來(lái)源：
    Baculovirus
  • 其他：
  • 中文名稱(chēng)：
    Recombinant Human Cbp/p300-interacting transactivator 2(CITED2),Yeast
  • 貨號(hào)：
    CSB-MP859529HU
  • 規(guī)格：
  • 來(lái)源：
    Mammalian cell
  • 其他：

產(chǎn)品詳情

  • 純度：
    >85% (SDS-PAGE)
  • 基因名：
  • Uniprot No.：
  • 別名：
    ASD8; Cbp/p300 interacting transactivator 2; Cbp/p300 interacting transactivator with Glu/Asp rich carboxy terminal domain 2; Cbp/p300-interacting transactivator 2; CITE2_HUMAN; CITED 2; CITED2; melanocyte-specific gene 1-related gene 1; MRG 1; MRG-1; MRG1; MSG related protein 1; MSG-related protein 1; MSG1-related gene 1; P35srj; VSD2
  • 種屬：
    Homo sapiens (Human)
  • 蛋白長(zhǎng)度：
    full length protein
  • 表達(dá)區(qū)域：
    1-270
  • 氨基酸序列
    MADHMMAMNH GRFPDGTNGL HHHPAHRMGM GQFPSPHHHQ QQQPQHAFNA LMGEHIHYGA GNMNATSGIR HAMGPGTVNG GHPPSALAPA ARFNNSQFMG PPVASQGGSL PASMQLQKLN NQYFNHHPYP HNHYMPDLHP AAGHQMNGTN QHFRDCNPKH SGGSSTPGGS GGSSTPGGSG SSSGGGAGSS NSGGGSGSGN MPASVAHVPA AMLPPNVIDT DFIDEEVLMS LVIEMGLDRI KELPELWLGQ NEFDFMTDFV CKQQPSRVSC
  • 蛋白標(biāo)簽：
    Tag?type?will?be?determined?during?the?manufacturing?process.
    The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.
  • 產(chǎn)品提供形式：
    Lyophilized powder
    Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
  • 復(fù)溶：
    We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
  • 儲(chǔ)存條件：
    Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
  • 保質(zhì)期：
    The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
    Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
  • 貨期：
    Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
    Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
  • 注意事項(xiàng)：
    Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
  • Datasheet ：
    Please contact us to get it.

產(chǎn)品評(píng)價(jià)

相關(guān)產(chǎn)品

靶點(diǎn)詳情

  • 功能：
    Transcriptional coactivator of the p300/CBP-mediated transcription complex. Acts as a bridge, linking TFAP2 transcription factors and the p300/CBP transcriptional coactivator complex in order to stimulate TFAP2-mediated transcriptional activation. Positively regulates TGF-beta signaling through its association with the SMAD/p300/CBP-mediated transcriptional coactivator complex. Stimulates the peroxisome proliferator-activated receptors PPARA transcriptional activity. Enhances estrogen-dependent transactivation mediated by estrogen receptors. Acts also as a transcriptional corepressor; interferes with the binding of the transcription factors HIF1A or STAT2 and the p300/CBP transcriptional coactivator complex. Participates in sex determination and early gonad development by stimulating transcription activation of SRY. Plays a role in controlling left-right patterning during embryogenesis; potentiates transcriptional activation of NODAL-mediated gene transcription in the left lateral plate mesoderm (LPM). Plays an essential role in differentiation of the adrenal cortex from the adrenogonadal primordium (AGP); stimulates WT1-mediated transcription activation thereby up-regulating the nuclear hormone receptor NR5A1 promoter activity. Associates with chromatin to the PITX2 P1 promoter region.
  • 基因功能參考文獻(xiàn)：
    1. Knockdown of CITED2 led to a decreased interaction of p53 with its inhibitor MDM2, which results in increased amounts of total p53 protein. Data indicate that CITED2 functions in pathways regulating p53 activity. PMID: 29072699
    2. CITED2 regulates primary breast tumor growth, likely by influencing tumor vasculature via TGF-beta-dependent regulation of VEGFA. PMID: 28008154
    3. The results suggest that CITED2 mutations in conserved regions lead to disease-causing biological and functional changes and may contribute to the occurrence of conotruncal heart defects in Chinese children. PMID: 28436679
    4. CITED2 gene mutation may play a significant role in the development of pediatric congenital heart disease. PMID: 28687891
    5. CITED2 supports gastric cancer cell colony formation and proliferation while inhibiting apoptosis making it a potential gene therapy target for gastric cancer. PMID: 28501104
    6. Through allosteric enhancement of HIF-1alpha release, CITED2 activates a highly responsive negative feedback circuit that rapidly and efficiently attenuates the hypoxic response, even at modest CITED2 concentrations. PMID: 28273070
    7. down-regulation of Cited2 was associated with high glucose-induced apoptosis in cardiomyocytes in vitro PMID: 27680315
    8. High Cited2 level in cumulus cells was associated with low embryo quality and pregnancy outcome in in vitro fertilization patients. PMID: 26812245
    9. the downregulation of CITED2 contributes to TGFbeta-mediated senescence. PMID: 28084522
    10. CITED2 plays important roles in the progression and chemoresistance of breast carcinoma and that CITED2 status is a potent prognostic factor in breast cancer patients. PMID: 27627783
    11. Intrinsic protein disorder plays a prominent role in the function and interactions of the transcriptional co-activators CBP and p300. (Review) PMID: 26851278
    12. FBXL5-mediated degradation of CITED2 leads to the activation of HIF-1 alpha. PMID: 25956243
    13. The increased CITED2 expression in acute myeloid leukemia results in better hematopoietic stem cell survival, lower PU.1 levels, and perturbed myeloid differentiation program that contributes to leukemia persistence. PMID: 25184385
    14. CITED2 has a potential causative impact on congenital heart disease PMID: 24848765
    15. Our study suggests that CITED2 gene mutations and methylation may play an important role in the development of pediatric congenital heart disease. PMID: 24456003
    16. data indicate that CITED2 functions as a transcriptional co-activator of ER in breast cancer cells and that its increased expression in tumors may result in estrogen-independent ER activation PMID: 23811274
    17. CITED2 is a direct effector of PPARgamma for tumor suppression. PMID: 23212831
    18. CITED2 functions as a molecular switch of TGF-alpha and TGF-beta-induced growth control, and MYC-CITED2 signaling axis provides a new index for predicting clinical outcome. PMID: 22814619
    19. CITED2 is phosphorylated by MAPK1 in vitro at T166, and that MAPK1 activation enhances the coactivation function of CITED2 but not of CITED2-T166N. PMID: 23082118
    20. We conclude that mutations in CITED2 may be involved in premature ovarian failure pathogenesis. PMID: 22709740
    21. CITED2 variants decreased its ability to mediate the expression of vascular endothelial growth factor (VEGF) and the expression of the paired-like homeodomain transcription factor 2-gamma (PITX2C), both of which are closely related to cardiac development. PMID: 22735262
    22. A combination of cisplatin and CITED2 shRNA may represent an effective treatment against p53-sensitive cancer cells. PMID: 21660965
    23. CITED2 activation may induce mucosal apoptosis and erosion by activating p53 and thus play a critical role in linking enteric bacteria with mucosal inflammation in ulcerative colitis. PMID: 21165656
    24. CITED2 is a novel regulator of NF-kappaB in the nucleus, which reveals a negative feedback mechanism for NF-kappaB signaling. PMID: 21098220
    25. CITED2 may act as a mechanosensitive molecular switch regulating cartilage matrix breakdown. PMID: 20392269
    26. Reducing CITED2 expression in a mammary tumor cell line inhibits the establishment of bone metastasis and osteolysis in vivo. PMID: 19642106
    27. Both TGFbeta and flow shear stimulated expression of CITED2 and also association of CIT-ED2 with p300 by dissociating Ets-1 from p300. Thus, CITED2 plays a major role in shear-induced down-regulation of MMP-1 and MMP-13 via a TGFbeta-dependent pathway. PMID: 12960175
    28. CIT-ED2 is a coactivator of PPARalpha and both proteins may participate in signaling cascades of hypoxic response and angiogenesis PMID: 15051727
    29. CITED2 mutations have a causative impact in the development of CHD in humans. PMID: 16287139
    30. TGF-beta-mediated down-regulation of Cited2 is post-transcriptional, through the Smad pathway, and requires the presence of its coding sequence PMID: 16675452
    31. Cited2, a coactivator of HNF4alpha, is essential for liver development PMID: 17932483
    32. CITED2 regulates colon cancer invasion and might be a target for histone deacetylase inhibitor-based intervention of colon cancer. PMID: 18054336
    33. CITED2 and PBX1 are likely to be important mediators of adrenal development and function in humans, but mutations in these genes are not common causes of adrenal failure. PMID: 18984668
    34. The effects of endothelial-cell-conditioned medium (ECCM), as produced during the incubation of human umbilical vein endothelial cells for 24 h, on the promoter activity and mRNA and protein expression of CITED2 in adrenocortical cells, was examined. PMID: 19319572
    35. Both NCOR2 and CITED2 mRNA levels were associated with MFS, that is, tumour aggressiveness, independently of traditional prognostic factors PMID: 19904269

    顯示更多

    收起更多

  • 相關(guān)疾病：
    Ventricular septal defect 2 (VSD2); Atrial septal defect 8 (ASD8)
  • 亞細(xì)胞定位：
    Nucleus. Note=Colocalizes with EP300 in dot-like structures.
  • 蛋白家族：
    CITED family
  • 數(shù)據(jù)庫(kù)鏈接：

    HGNC: 1987

    OMIM: 602937

    KEGG: hsa:10370

    STRING: 9606.ENSP00000356623

    UniGene: Hs.82071